What is the appropriate management for a 74‑year‑old man with non‑ST‑segment elevation myocardial infarction, elevated troponin, and absent chest pain?

Management of NSTEMI with High Troponin and No Chest Pain in a 74-Year-Old Man

This 74-year-old man with NSTEMI and elevated troponin requires immediate admission to a monitored unit with continuous rhythm monitoring, dual antiplatelet therapy (aspirin plus ticagrelor), and invasive coronary angiography within 24 hours regardless of the absence of chest pain 1.

Immediate Actions and Monitoring

The absence of chest pain does not change the diagnosis or management approach when troponin elevation and other diagnostic criteria confirm NSTEMI. Admit this patient immediately to a monitored unit with continuous rhythm monitoring until the diagnosis is fully established 1. For a 74-year-old, rhythm monitoring should extend beyond 24 hours given the increased risk for cardiac arrhythmias in elderly patients 1.

Diagnostic Confirmation

While the diagnosis appears established with elevated troponin, ensure:

• A 12-lead ECG was obtained within 10 minutes of medical contact and interpreted by an experienced physician 1
• Serial troponin measurements using high-sensitivity assays were performed (0h/1h or 0h/2h algorithm) 1
• Additional ECG leads (V3R, V4R, V7-V9) if standard leads are inconclusive 1
• Echocardiography to evaluate regional and global LV function and exclude differential diagnoses 1

Important caveat: The elevated troponin conveys high risk and indicates need for intensive management regardless of symptom presentation 2. Troponin elevations correlate with infarct size and risk of death 2.

Antiplatelet Therapy (Start Immediately)

Initiate dual antiplatelet therapy without delay 1:

Aspirin:

• Loading dose: 150-300 mg oral (or 75-250 mg IV if unable to take oral)
• Maintenance: 75-100 mg daily long-term

P2Y12 Inhibitor - Choose based on this algorithm:

• First choice: Ticagrelor 180 mg loading dose, then 90 mg twice daily 1
  • Preferred because it can be used irrespective of invasive vs. conservative strategy
  • No dose adjustment needed for age alone
• Alternative: Prasugrel (if proceeding to PCI and patient is P2Y12 inhibitor-naïve)
  • Critical for this 74-year-old: Use reduced dose of 5 mg daily (after 60 mg loading dose) due to age ≥75 years 1
• Last resort: Clopidogrel 300-600 mg loading, 75 mg daily - only if prasugrel or ticagrelor unavailable 1

Maintain dual antiplatelet therapy for 12 months unless excessive bleeding risk or contraindications develop 1.

Timing of Invasive Strategy

Perform coronary angiography within 24 hours of presentation 1, 2. The 2020 ESC guidelines recommend this timeframe for NSTEMI patients with elevated troponin, even without ongoing chest pain.

Accelerate to within 2 hours if any of these develop:

• Hemodynamic instability
• Recurrent chest pain/ischemia
• Life-threatening arrhythmias
• Mechanical complications

The high troponin level itself indicates substantial myocardial injury and warrants prompt revascularization 3. Recent data shows patients with higher troponin levels at presentation face elevated mortality risk (HR 2.06 in adjusted models), emphasizing the importance of timely intervention 3.

Additional Medical Therapies

Anticoagulation: Start unfractionated heparin or low-molecular-weight heparin in addition to dual antiplatelet therapy 1. Consider adding a glycoprotein IIb/IIIa receptor antagonist if using unfractionated heparin 2.

Oxygen: Only administer supplemental oxygen if arterial oxygen saturation <90%, respiratory distress, or other high-risk features of hypoxemia 2. Do not give routine oxygen to normoxic patients.

Other supportive care:

• Beta-blockers (if no contraindications)
• Statin therapy
• ACE inhibitor or ARB (especially if LV dysfunction present)
• Nitrates for symptom relief if chest pain develops

Special Considerations for Elderly Patients

At age 74, this patient requires particular attention to 4:

• Bleeding risk assessment: Elderly patients have higher bleeding risk with antithrombotic therapy
• Renal function: Check creatinine clearance for medication dosing adjustments
• Frailty assessment: Frailty is associated with worse prognosis in elderly cardiovascular patients
• Polypharmacy: Review all medications for interactions
• Cognitive function: Ensure understanding of medication regimen

Common Pitfalls to Avoid

1. Do not delay invasive management due to absence of chest pain - troponin elevation alone defines high risk 2
2. Do not use full-dose prasugrel (10 mg) in this 74-year-old - must use 5 mg daily due to age ≥75 1
3. Do not measure additional biomarkers (h-FABP, copeptin, BNP) for routine diagnostic purposes - they add no value beyond hs-cTn 1
4. Do not discharge with outpatient stress testing - elevated troponin mandates inpatient management 2
5. Exclude macrotroponin interference if troponin elevation seems discordant with clinical picture, though this is rare 5

Risk Stratification Beyond Initial Management

Serial troponin measurements provide prognostic information beyond the initial diagnostic role 1. Persistent elevation at 72-96 hours after symptom onset may provide relevant information about infarct size and mortality risk 2. However, this should not delay the initial invasive strategy.